Placebo’s Double Whammy

Sham treatments can both reduce pain and increase pleasure, and do so affecting similar circuitry in the brain.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, ROBIN_24Expectations give placebos their power, allowing them to dramatically alter our experience of a stimulus. Researchers demonstrate in Proceedings of the National Academy of Sciences today (October 14) that not only can placebos tamp down feelings of pain, they can also ramp up pleasurable sensations. It all depends on where a person starts. If she is expecting an improvement in pain, her sensory processing decreases. If, on the other hand, she anticipates a heightened sense of pleasure, then the sensory processing is magnified.

The researchers, led by Dan-Mikael Ellingsen at Gothenburg University in Sweden, offered a nasal spray placebo (supposedly containing oxytocin) or nothing at all to 30 study participants. On one day, the participants received gentle strokes on the left arm; on another day, a painful heat stimulus. In the pain scenario, the nasal spray was tied to a decrease in pain sensation, and in the pleasure scenario, it was associated with an increase in pleasure, compared to the times when the person was given no spray.

Using functional MRI, the researchers found increases in activity in the posterior insula and primary and secondary somatosensory areas—regions involved in sensory processing—during the pleasurable arm stroke placebo treatments. They also found decreases in these areas during the painful heat ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies